Search

This webinar provides an overview of the current regulatory landscape in the UK and the EU and provides practical advice on what businesses operating in Europe should do to ensure they remain compliant.

The SEC is rethinking disclosure rules for foreign private issuers. Could new regulations mean greater transparency—or push companies off US exchanges?

In this webinar, we walk through the key insurance and risk management milestones life science companies should prepare for as they move from early funding through clinical trials, IPO, and commercialization.

In this Q1 2025 Commercial Lines Insurance Market Update, we review insurance rates and pricing trends across various segments.